Pilot study of avocado supplementation in an L-NAME rat model of hypertension and systemic injury
Journal of Dietitians Association of Nigeria · 2026 · 17 (1) · 13-24
DOI: 10.4314/jdan.v17i1.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dietitians Association of Nigeria, 2026. Verfasst von Joy A.C. Amadi und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Endothelial dysfunction, hypertension, and multi-organ injury are major contributors to cardiovascular disease. Avocado (Persea americana) is rich in monounsaturated fatty acids, phytosterols, and antioxidants, but its protective effects against hypertension-induced systemic injury remain incompletely understood.
Objectives
To evaluate the effects of avocado pulp supplementation on L-NAME-induced hypertension and multi-organ injury in a rat model of nitric oxide synthase inhibition, and to provide proof-of-concept evidence supporting its potential role in cardiovascular and metabolic disease prevention.
Methods
Male Wistar rats (n = 4/group) were randomized into six groups: control, avocado, L-NAME, L-NAME+losartan+metoprolol succinate, L-NAME+avocado, and L-NAME+metoprolol succinate+avocado. Randomization used sealed opaque envelopes, and outcome assessment was blinded. Avocado pulp was incorporated into the diet at 80% (w/w). Outcomes included blood pressure, hematological parameters, liver enzymes, renal function, and systolic-diastolic blood pressure correlations. Data were analyzed using one-way ANOVA with Tukey's post hoc tests.
Results
L-NAME significantly increased systolic (+18 mmHg), diastolic (+20 mmHg), and mean arterial pressure (+17 mmHg) compared with controls (all p < 0.01). Avocado supplementation reduced these elevations by approximately 15–18 mmHg, restoring values near baseline. L-NAME also increased platelet counts (p = 0.031), elevated ALT (p = 0.044), and significantly increased urea (+25 mg/dL) and creatinine (+0.8 mg/dL; p < 0.01). Avocado supplementation attenuated these changes, reducing renal markers by 20–30% and maintaining liver enzyme levels near control values. Electrolytes remained unchanged. Correlation analysis showed pathological systolic-diastolic coupling in L-NAME rats (r = 0.78), which was abolished with avocado supplementation (r = 0.00).
Conclusion
This pilot proof-of-concept study demonstrates that avocado pulp supplementation attenuated L-NAME-induced hypertension and improved renal, hepatic, and hematological indices in rats. These findings provide biological plausibility for avocado as a dietary strategy to reduce cardiovascular and metabolic risk and support further investigation in larger, adequately powered preclinical and clinical studies.
Zitieren
APA
Amadi, J. A., Aloy-Amadi, O. A., Chukwu, C. H., & Amadi, P. U. (2026). Pilot study of avocado supplementation in an L-NAME rat model of hypertension and systemic injury. Journal of Dietitians Association of Nigeria, 17(1), 13-24. https://doi.org/10.4314/jdan.v17i1.2
Vancouver
Amadi JA, Aloy-Amadi OA, Chukwu CH, Amadi PU. Pilot study of avocado supplementation in an L-NAME rat model of hypertension and systemic injury. Journal of Dietitians Association of Nigeria. 2026;17(1):13-24. doi:10.4314/jdan.v17i1.2
BibTeX
@article{Amadi2026,
author = {Amadi, Joy A.C. and Aloy-Amadi, Oluchi A. and Chukwu, Chukwuma H. and Amadi, Peter U.},
title = {Pilot study of avocado supplementation in an L-NAME rat model of hypertension and systemic injury},
journal = {Journal of Dietitians Association of Nigeria},
year = {2026},
volume = {17},
number = {1},
pages = {13--24},
doi = {10.4314/jdan.v17i1.2}
}
EUVIMED